Literature DB >> 16130192

Resistin levels of serum and follicular fluid in non-obese patients with polycystic ovary syndrome during IVF cycles.

Xiu-E Lu1, He-Feng Huang, Mei-Gen Li, Yi-Min Zhu, Yu-Li Qiang, Min-Yue Dong.   

Abstract

OBJECTIVES: To measure serum and follicular resistin, steroids hormone levels in women with PCOS (polycystic ovary syndrome) (BMI (body mass index)<25 kg/m(2)), to assess possible correlations of resistin to hormonal and metabolic parameters and to analyze the clinical outcomes of in vitro fertilization-embryo transfer (IVF-ET) in women with PCOS and tubal infertility. STUDY
DESIGN: We analyzed the clinical outcomes of IVF-ET in women with PCOS (BMI<25 kg/m(2)) and tubal infertility during the years 2002 to 2004 and compared the serum and follicular fluid resistin levels, estradiol (E(2)), progesterone (P), testosterone (T) levels in 20 PCOS and 20 healthy, age-matched women without PCOS during IVF-stimulated cycles. The correlations between the resistin levels and the outcomes of IVF-ET were evaluated.
RESULTS: No significant differences in resistin levels of either serum or follicular fluid between PCOS and control group were found. However, resistin levels in serum were higher than that in follicular fluid in both groups. Multiple regression analysis showed that resistin levels in serum did not correlate with BMI, estradiol, LH (luteinizing hormone) and insulin level in fasting blood. No significant correlations were found between follicular fluid reisistin levels and fertilization rate, implantation rate, clinical pregnancy rate or early miscarriage rate in both PCOS and control groups.
CONCLUSION: Our results show that resistin does not have correlation with the hormonal and metabolic parameters as well as the outcomes of IVF. These data suggest that resistin is unlikely to be a local determinant factor in steroidogenesis and growth and maturation of oocytes during IVF-ET in lean women with PCOS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16130192      PMCID: PMC1389908          DOI: 10.1631/jzus.2005.B0897

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  23 in total

1.  Serum and follicular resistin levels in women with polycystic ovarian syndrome during IVF-stimulated cycles.

Authors:  Kok-Min Seow; Chi-Chang Juan; Yung-Pei Hsu; Low-Tone Ho; Yuan-Yung Wang; Jiann-Loung Hwang
Journal:  Hum Reprod       Date:  2004-10-28       Impact factor: 6.918

2.  Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome.

Authors:  Ghina Ghazeeri; William H Kutteh; Michael Bryer-Ash; Derek Haas; Raymond W Ke
Journal:  Fertil Steril       Date:  2003-03       Impact factor: 7.329

3.  The hormone resistin links obesity to diabetes.

Authors:  C M Steppan; S T Bailey; S Bhat; E J Brown; R R Banerjee; C M Wright; H R Patel; R S Ahima; M A Lazar
Journal:  Nature       Date:  2001-01-18       Impact factor: 49.962

4.  Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists.

Authors:  J M Way; C Z Görgün; Q Tong; K T Uysal; K K Brown; W W Harrington; W R Oliver; T M Willson; S A Kliewer; G S Hotamisligil
Journal:  J Biol Chem       Date:  2001-05-23       Impact factor: 5.157

5.  Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone.

Authors:  D T Vandermolen; V S Ratts; W S Evans; D W Stovall; S W Kauma; J E Nestler
Journal:  Fertil Steril       Date:  2001-02       Impact factor: 7.329

6.  Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance.

Authors:  Kok-Min Seow; Chi-Chang Juan; Liang-Yi Wu; Yung-Pei Hsu; Wei-Ming Yang; Yieh-Loong Tsai; Jiann-Loung Hwang; Low-Tone Ho
Journal:  Hum Reprod       Date:  2004-01       Impact factor: 6.918

7.  Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease.

Authors:  G A Burghen; J R Givens; A E Kitabchi
Journal:  J Clin Endocrinol Metab       Date:  1980-01       Impact factor: 5.958

8.  Serum resistin levels in women with polycystic ovary syndrome.

Authors:  Dimitrios Panidis; Georgios Koliakos; Anargyros Kourtis; Dimitrios Farmakiotis; Tzant Mouslech; David Rousso
Journal:  Fertil Steril       Date:  2004-02       Impact factor: 7.329

9.  Variation in resistin gene promoter not associated with polycystic ovary syndrome.

Authors:  Margrit Urbanek; Yangzhu Du; Kaisa Silander; Francis S Collins; Claire M Steppan; Jerome F Strauss; Andrea Dunaif; Richard S Spielman; Richard S Legro
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461

10.  Relationship of weight to successful induction of ovulation with clomiphene citrate.

Authors:  M K Shepard; J P Balmaceda; C G Leija
Journal:  Fertil Steril       Date:  1979-12       Impact factor: 7.329

View more
  8 in total

1.  E-selectin, resistin and reactive oxygen species levels in GnRH -agonist and -antagonist protocols in IVF/ICSI: a prospective cohort study.

Authors:  Charalampos Siristatidis; Marily Askoxylaki; Christos Varounis; Dimitrios Kassanos; Charalampos Chrelias
Journal:  J Assist Reprod Genet       Date:  2015-05-01       Impact factor: 3.412

2.  Comparison of semen quality and outcome of assisted reproductive techniques in Chinese men with and without hepatitis B.

Authors:  Xu-Ping Zhou; Xiao-Ling Hu; Yi-Min Zhu; Fan Qu; Sai-Jun Sun; Yu-Li Qian
Journal:  Asian J Androl       Date:  2011-03-14       Impact factor: 3.285

Review 3.  Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence.

Authors:  Jie Qiao; Huai L Feng
Journal:  Hum Reprod Update       Date:  2010-07-16       Impact factor: 15.610

4.  Blood Circulating Levels of Adipokines in Polycystic Ovary Syndrome Patients: A Systematic Review and Meta-analysis.

Authors:  Sanaz Mehrabani; Arman Arab; Elham Karimi; Mehran Nouri; Marjan Mansourian
Journal:  Reprod Sci       Date:  2021-09-01       Impact factor: 2.924

5.  Novel oncogenic and chemoresistance-inducing functions of resistin in ovarian cancer cells require miRNAs-mediated induction of epithelial-to-mesenchymal transition.

Authors:  Ling Qiu; Guo-Feng Zhang; Lei Yu; Hong-Yong Wang; Xiao-Jing Jia; Tie-Jun Wang
Journal:  Sci Rep       Date:  2018-08-21       Impact factor: 4.379

6.  Assessing the variability and predictability of adipokines (adiponectin, leptin, resistin and their ratios) in non-obese and obese women with anovulatory polycystic ovary syndrome.

Authors:  Christian Obirikorang; William K B A Owiredu; Sandra Adu-Afram; Emmanuel Acheampong; Evans Adu Asamoah; Enoch Kwabena Antwi-Boasiakoh; Eddie-Williams Owiredu
Journal:  BMC Res Notes       Date:  2019-08-15

7.  Circulating resistin and follistatin levels in obese and non-obese women with polycystic ovary syndrome: A systematic review and meta-analysis.

Authors:  Tahereh Raeisi; Hossein Rezaie; Mina Darand; Akram Taheri; Nazila Garousi; Bahman Razi; Leonardo Roever; Reza Mohseni; Shimels Hussien Mohammed; Shahab Alizadeh
Journal:  PLoS One       Date:  2021-03-19       Impact factor: 3.240

8.  Elevated Adipsin and Reduced C5a Levels in the Maternal Serum and Follicular Fluid During Implantation Are Associated With Successful Pregnancy in Obese Women.

Authors:  Manjunath Ramanjaneya; Ilhame Diboun; Najeha Rizwana; Yaser Dajani; Lina Ahmed; Alexandra E Butler; Thoraya Ali Almarzooqi; Mohammed Shahata; Moza Khalaf Al Bader; Einas Elgassim; Hasan Burjaq; Stephen L Atkin; Abdul-Badi Abou-Samra; Mohamed A Elrayess
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-13       Impact factor: 6.055

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.